191 related articles for article (PubMed ID: 30076264)
1. Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization.
Sardar Pasha SPB; Sishtla K; Sulaiman RS; Park B; Shetty T; Shah F; Fishel ML; Wikel JH; Kelley MR; Corson TW
J Pharmacol Exp Ther; 2018 Oct; 367(1):108-118. PubMed ID: 30076264
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo.
Jiang A; Gao H; Kelley MR; Qiao X
Vision Res; 2011 Jan; 51(1):93-100. PubMed ID: 20937296
[TBL] [Abstract][Full Text] [Related]
3. Suppression of choroidal neovascularization through inhibition of APE1/Ref-1 redox activity.
Li Y; Liu X; Zhou T; Kelley MR; Edwards PA; Gao H; Qiao X
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4461-9. PubMed ID: 24970265
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization.
Li Y; Liu X; Zhou T; Kelley MR; Edwards P; Gao H; Qiao X
Redox Biol; 2014; 2():485-94. PubMed ID: 24624338
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis.
Sahakian L; Filippone RT; Stavely R; Robinson AM; Yan XS; Abalo R; Eri R; Bornstein JC; Kelley MR; Nurgali K
Inflamm Bowel Dis; 2021 Feb; 27(3):388-406. PubMed ID: 32618996
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy.
Hartman GD; Lambert-Cheatham NA; Kelley MR; Corson TW
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638620
[TBL] [Abstract][Full Text] [Related]
7. Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth.
Fishel ML; Jiang Y; Rajeshkumar NV; Scandura G; Sinn AL; He Y; Shen C; Jones DR; Pollok KE; Ivan M; Maitra A; Kelley MR
Mol Cancer Ther; 2011 Sep; 10(9):1698-708. PubMed ID: 21700832
[TBL] [Abstract][Full Text] [Related]
8. APE1/Ref-1 redox-specific inhibition decreases survivin protein levels and induces cell cycle arrest in prostate cancer cells.
McIlwain DW; Fishel ML; Boos A; Kelley MR; Jerde TJ
Oncotarget; 2018 Feb; 9(13):10962-10977. PubMed ID: 29541389
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
[TBL] [Abstract][Full Text] [Related]
10. A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity.
Ando K; Hirao S; Kabe Y; Ogura Y; Sato I; Yamaguchi Y; Wada T; Handa H
Nucleic Acids Res; 2008 Aug; 36(13):4327-36. PubMed ID: 18586825
[TBL] [Abstract][Full Text] [Related]
11. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
Fishel ML; Wu X; Devlin CM; Logsdon DP; Jiang Y; Luo M; He Y; Yu Z; Tong Y; Lipking KP; Maitra A; Rajeshkumar NV; Scandura G; Kelley MR; Ivan M
J Biol Chem; 2015 Jan; 290(5):3057-68. PubMed ID: 25492865
[TBL] [Abstract][Full Text] [Related]
12. APE1/Ref-1 as a Novel Target for Retinal Diseases.
Heisel C; Yousif J; Mijiti M; Charizanis K; Brigell M; Corson TW; Kelley MR
J Cell Signal; 2021; 2(2):133-138. PubMed ID: 34322687
[TBL] [Abstract][Full Text] [Related]
13. Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1.
Luo M; Delaplane S; Jiang A; Reed A; He Y; Fishel M; Nyland RL; Borch RF; Qiao X; Georgiadis MM; Kelley MR
Antioxid Redox Signal; 2008 Nov; 10(11):1853-67. PubMed ID: 18627350
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.
Zheng Y; Gu Q; Xu X
Acta Ophthalmol; 2012 Nov; 90(7):e512-23. PubMed ID: 22994140
[TBL] [Abstract][Full Text] [Related]
15. Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.
Mijit M; Liu S; Sishtla K; Hartman GD; Wan J; Corson TW; Kelley MR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674619
[TBL] [Abstract][Full Text] [Related]
16. New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types.
Gampala S; Moon HR; Wireman R; Peil J; Kiran S; Mitchell DK; Brewster K; Mang H; Masters A; Bach C; Smith-Kinnamen W; Doud EH; Rai R; Mosley AL; Quinney SK; Clapp DW; Hamdouchi C; Wikel J; Zhang C; Han B; Georgiadis MM; Kelley MR; Fishel ML
Pharmacol Res; 2024 Mar; 201():107092. PubMed ID: 38311014
[TBL] [Abstract][Full Text] [Related]
17. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
18. Role of Autophagy in Hypoxia-Induced Angiogenesis of RF/6A Cells in vitro.
Li R; Du J; Chang Y
Curr Eye Res; 2016 Dec; 41(12):1566-1570. PubMed ID: 27259688
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammatory role of extranuclear apurinic/apyrimidinic endonuclease 1/redox effector factor-1 in reactive astrocytes.
Baek H; Lim CS; Byun HS; Cho HS; Lee YR; Shin YS; Kim HW; Jeon BH; Kim DW; Hong J; Hur GM; Park JB
Mol Brain; 2016 Dec; 9(1):99. PubMed ID: 27986089
[TBL] [Abstract][Full Text] [Related]
20. Identification and Characterization of New Chemical Entities Targeting Apurinic/Apyrimidinic Endonuclease 1 for the Prevention of Chemotherapy-Induced Peripheral Neuropathy.
Kelley MR; Wikel JH; Guo C; Pollok KE; Bailey BJ; Wireman R; Fishel ML; Vasko MR
J Pharmacol Exp Ther; 2016 Nov; 359(2):300-309. PubMed ID: 27608656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]